25周年を記念 1999-2024
*3年間で¥ 153396、たったの¥ 61358
フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Saniona AB’s Nomination Committee for the Annual General Meeting 2023 PRESS RELEASE November 25, 2022 Saniona (OMX: SANION), a clinical...
Saniona publishes its interim report for the third quarter of 2022 Three Months Ended September 30, 2022 (2021)Nine Months Ended September...
Saniona’s anti-inflammatory and anti-fibrotic candidate SAN903 is ready for clinical studies PRESS RELEASE November 3, 2022 SAN903 has...
Saniona extends runway and amends loan agreement with Formue Nord PRESS RELEASE September 30, 2022 Saniona (OMX: SANION), a clinical stage...
Saniona publishes its interim report for the second quarter of 2022 Three Months Ended June 30, 2022 (2021)Six Months Ended June 30, 2022...
Bulletin from the Saniona AB extraordinary general meeting on August 18, 2022 PRESS RELEASE August 18, 2022 Today, on August 18, 2022, an...
Saniona progresses its Kv7 epilepsy program into Lead Optimization PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage...
Saniona provides update on outstanding option programs PRESS RELEASE August 5, 2022 Saniona (OMX: SANION), a clinical stage...
Notice of extraordinary general meeting in Saniona AB PRESS RELEASE 15 July 2022 The English text is an unofficial translation. In case of...
Saniona CEO Thomas Feldthus and board member Carl Johan Sundberg purchase Saniona shares in the open market PRESS RELEASE July 6, 2022...
Saniona reports positive top line results from the SAN711 Phase 1 Clinical Trial PRESS RELEASE June 30, 2022 Saniona (OMX: SANION), a...
Saniona’s preclinical candidate SAN903 shows robust dampening of fibrosis in Chronic Kidney Disease model PRESS RELEASE June 24, 2022...
Bulletin from the Saniona AB annual shareholders’ meeting on May 25, 2022 PRESS RELEASE May 25, 2022 Today, on May 25, 2022, the annual...
Saniona publishes its interim report for the first quarter of 2022 Q1 2022 (Q1 2021) Revenue was SEK 6.6 M (3.4 M)Operating loss was SEK...
Saniona´s Clinical Trial in Hypothalamic Obesity Published in Scientific Journal PRESS RELEASE May 23, 2022 Saniona (OMX: SANION), a...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約